FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

46 hedge funds and large institutions have $28.2M invested in Fate Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 12 closing their positions.

Holders
46
Holders Change
-8
Holders Change %
-14.81%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
19
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BGA
1
Belmont Global Advisors
Texas
$868K
2
BCM
2
Bridgeway Capital Management
Texas
$854K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.14M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$368K
5
Goldman Sachs
5
Goldman Sachs
New York
$313K

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$0
2
BC
2
Broadfin Capital
New York
$0
3
RG
3
Redmile Group
California
$2.68M
4
KCM
4
Kingdon Capital Management
New York
$4.06M
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
51
Citadel Advisors
Florida
– -$49K -14,464 Closed
Nomura Holdings
52
Nomura Holdings
Japan
– -$44K -13,000 Closed
TCM
53
Tufton Capital Management
Maryland
– -$40K -11,858 Closed
IA
54
IFP Advisors
Florida
– -$18K -5,200 Closed
Acadian Asset Management
55
Acadian Asset Management
Massachusetts
– -$3K -1,038 Closed
1 2
3